Furthermore, FHOD1’s overexpression in glioblastoma and melanoma underscores its role in promoting tumor invasion and metastasis, marking it as a potential target for therapeutic interventions and a marker of advanced disease stages in cancers like gastric cancer (33, 34). This evidence concerns the gene FHOD1 and neoplasm.